BioAtla, Inc.
BioAtla, Inc. (BCAB) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 302 transactions totaling $92.5M, demonstrating a bearish sentiment with -$11.7M in net insider flow. The most recent transaction on Nov 30, 2025 involved a transaction of 1,566 shares valued at $1.4K.
BCAB Insider Activity Summary
Who Is Buying BCAB Stock?
No significant insider buying has been recorded for BCAB in the recent period.
Who Is Selling BCAB Stock?
No significant insider selling has been recorded for BCAB in the recent period.
Is BioAtla, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for BCAB is bearish with an Insider Alignment Score of 44/100 and a net flow of -$11.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
BCAB Frequently Asked Questions
Understanding BCAB Insider Activity
Insider trading at BioAtla, Inc. (BCAB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading BCAB stock, having executed 302 transactions in the past 90 days. The most active insider is Guy Levy (Executive), who has made 9 transactions totaling $69.8M.
Related Tools
Track BioAtla, Inc. Insider Activity
Get notified when executives and directors at BCAB file new Form 4 transactions